Search
Fate Therapeutics Inc
FATEAdd to Watchlist
2.470USD
+0.040+1.65%
Close 07-27 16:00（ET）Quotes delayed by 15 min
287.19MMarket Cap
LossP/E TTM
Fate Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-27The current valuation score of Fate Therapeutics Inc is 7.83, ranking 188 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.23, which is -79.42% below the recent high of -0.46 and -129.00% above the recent low of -5.11.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.